Cargando…
P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429289/ http://dx.doi.org/10.1097/01.HS9.0000847000.38667.91 |
| _version_ | 1784779394098659328 |
|---|---|
| author | Palandri, F. Ross, D. M. Cochrane, T. Tate, C. Lane, S. W. Larsen, S. R. Gerds, A. T. Halpern, A. B. Shortt, J. Rossetti, J. M. Pettit, K. M. Liang, J. Mead, A. Marchetti, M. Vannucchi, A. Wilson, A. Göthert, J. R. Hanna, M. Jones, A. Peppe, J. Natsoulis, G. McClure, T. Hong, W.-J. Stevenson, W. S. Harrison, C. N. Talpaz, M. Vianelli, N. Rienhoff, H. Y. |
| author_facet | Palandri, F. Ross, D. M. Cochrane, T. Tate, C. Lane, S. W. Larsen, S. R. Gerds, A. T. Halpern, A. B. Shortt, J. Rossetti, J. M. Pettit, K. M. Liang, J. Mead, A. Marchetti, M. Vannucchi, A. Wilson, A. Göthert, J. R. Hanna, M. Jones, A. Peppe, J. Natsoulis, G. McClure, T. Hong, W.-J. Stevenson, W. S. Harrison, C. N. Talpaz, M. Vianelli, N. Rienhoff, H. Y. |
| author_sort | Palandri, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429289 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292892022-08-31 P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) Palandri, F. Ross, D. M. Cochrane, T. Tate, C. Lane, S. W. Larsen, S. R. Gerds, A. T. Halpern, A. B. Shortt, J. Rossetti, J. M. Pettit, K. M. Liang, J. Mead, A. Marchetti, M. Vannucchi, A. Wilson, A. Göthert, J. R. Hanna, M. Jones, A. Peppe, J. Natsoulis, G. McClure, T. Hong, W.-J. Stevenson, W. S. Harrison, C. N. Talpaz, M. Vianelli, N. Rienhoff, H. Y. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429289/ http://dx.doi.org/10.1097/01.HS9.0000847000.38667.91 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Palandri, F. Ross, D. M. Cochrane, T. Tate, C. Lane, S. W. Larsen, S. R. Gerds, A. T. Halpern, A. B. Shortt, J. Rossetti, J. M. Pettit, K. M. Liang, J. Mead, A. Marchetti, M. Vannucchi, A. Wilson, A. Göthert, J. R. Hanna, M. Jones, A. Peppe, J. Natsoulis, G. McClure, T. Hong, W.-J. Stevenson, W. S. Harrison, C. N. Talpaz, M. Vianelli, N. Rienhoff, H. Y. P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title | P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title_full | P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title_fullStr | P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title_full_unstemmed | P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title_short | P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) |
| title_sort | p1033: a phase 2 study of the lsd1 inhibitor img-7289 (bomedemstat) for the treatment of essential thrombocythemia (et) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429289/ http://dx.doi.org/10.1097/01.HS9.0000847000.38667.91 |
| work_keys_str_mv | AT palandrif p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT rossdm p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT cochranet p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT tatec p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT lanesw p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT larsensr p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT gerdsat p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT halpernab p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT shorttj p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT rossettijm p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT pettitkm p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT liangj p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT meada p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT marchettim p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT vannucchia p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT wilsona p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT gothertjr p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT hannam p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT jonesa p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT peppej p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT natsoulisg p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT mccluret p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT hongwj p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT stevensonws p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT harrisoncn p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT talpazm p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT vianellin p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet AT rienhoffhy p1033aphase2studyofthelsd1inhibitorimg7289bomedemstatforthetreatmentofessentialthrombocythemiaet |